Literature DB >> 24873158

[Outward versus inward placement in Shang Ring circumcision for phimosis and redundant prepuce in adult men: analysis of 527 cases].

Sheng-Tao Xie, Guang-Yu Chen, Qiao-Hong Wei, Xiao-Tong Liu, Lin Jiao, Yao Tang.   

Abstract

OBJECTIVE: To observe the clinical effects of two different circumcision procedures with the Shang Ring and compare their advantages and disadvantages.
METHODS: A total of 527 adult males with phimosis or redundant prepuce underwent Shang Ring circumcision by conventional outward replacement (n = 254) and inward placement (n = 273), respectively. We observed the in-ring nocturnal pain, complications, ring-removal pain, degree of edema, recovery time, and patients' satisfaction after surgery, and compared them between the two groups.
RESULTS: Compared with the conventional outward placement (5.9%) of the Shang Ring, the inward placement method showed the advantages of mild in-ring nocturnal pain, a low complication rate, significantly reduced ring-removal pain, and mild edema, but exhibited longer healing time.
CONCLUSION: In Shang Ring circumcision for phimosis and redundant prepuce in adult males, each of the outward and inward placement methods has advantages and disadvantages of its own, but the latter is more advantageous and feasible.

Entities:  

Mesh:

Year:  2014        PMID: 24873158

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  2 in total

1.  Circumcision with "no-flip Shang Ring" and "Dorsal Slit" methods for adult males: a single-centered, prospective, clinical study.

Authors:  Jun-Hao Lei; Liang-Ren Liu; Qiang Wei; Wen-Ben Xue; Tu-Run Song; Shi-Bing Yan; Lu Yang; Ping Han; Yu-Chun Zhu
Journal:  Asian J Androl       Date:  2016 Sep-Oct       Impact factor: 3.285

2.  Evaluation of clinical curative effects of disposable stitching instrument in redundant prepuce patients.

Authors:  Haitao Wang; Ningjie Chen; Ran Huo; Jincun Yang; Xia Li; Nan Xing
Journal:  Exp Ther Med       Date:  2017-05-11       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.